NRXS
Neuraxis, INC
Latest Form 4:Purchase$16KbyCarrico Brian Allen (Chief Executive Officer) · filed Apr 3, 2026
Neuraxis, INC (NRXS) has 19 SEC Form 4 filings (22 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Aug 26, 2026.
- Industry:Biotechnology
- CEO:Brian Carrico
- Employees:21
- HQ:Carmel, IN, US
- IPO:2023-08-09
Insider Buying
$1.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$74.8M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Carrico Brian AllenFirst filing | Chief Executive Officer | Purchase | 8,060 | $16K | Apr 3 | SEC ↗ |
Henrichs Timothy RobertFirst filing | Chief Financial Officer | Purchase | 7,593 | $15K | Apr 3 | SEC ↗ |
Carrico Thomas JoesephFirst filing | CRO, CCO, CPO | Purchase | 667 | $1K | Apr 3 | SEC ↗ |
Aharon GilFirst filing | Director | Purchase | 286,138 | $1.0M | Dec 29 | SEC ↗ |
Related companies
Neuraxis, INC is in the Healthcare sector.